Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Juan Guillermo Pérez-Carreño"'
Publikováno v:
Forensic Sciences Research, Vol 6, Iss 4, Pp 347-349 (2021)
Externí odkaz:
https://doaj.org/article/d339a80a13b74687a2c1ea0ede5c035c
Autor:
Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone count
Externí odkaz:
https://doaj.org/article/c33cd2861e594b3fbbba6b1c8570339a
Autor:
Juan Carlos Villar, Víctor Mauricio Herrera, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Yeny Zulay Castellanos Domínguez, Skarlet Marcell Vásquez, Zulma Milena Cucunubá, Nilda Graciela Prado, Yolanda Hernández
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-2 (2019)
Following publication of the original article [1], the authors notified us of a few requested editions that were not implemented adequately during proofing. The publisher apologizes for the inconvenience caused to our authors and readers.
Externí odkaz:
https://doaj.org/article/8693f80730fa4964a6d8f19942d1a4e0
Autor:
Juan Guillermo Pérez Carreño
Publikováno v:
REDIIS / Revista de Investigación e Innovación en Salud. 3:140-142
Autor:
Victor M. Herrera, Zulma M. Cucunubá, Yeny Zulay Castellanos Domínguez, Eliana Váquiro Herrera, Juan Carlos Villar, Skarlet Marcell Vásquez, Nilda Graciela Prado, Juan Guillermo Pérez Carreño, Yolanda Hernández
Publikováno v:
Sistema de Gestión del Conocimiento ANLIS MALBRÁN
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
Trials, Vol 20, Iss 1, Pp 1-2 (2019)
Administración Nacional de Laboratorios e Institutos de Salud "Dr. Carlos G. Malbrán"
instacron:ANLIS
Trials, Vol 20, Iss 1, Pp 1-2 (2019)
Fil: Hernández Yolanda. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Parasitología Dr. Mario Fatala Chaben. Departamento de Clínica, Patología y Tratamiento; Argentina. Following publication of the original article [1], the authors notified us of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c7e74f424368a22d3a86a9e1d687851
http://sgc.anlis.gob.ar/handle/123456789/874
http://sgc.anlis.gob.ar/handle/123456789/874
Autor:
Skarlet Marcell Vásquez, Zulma M. Cucunubá, Yolanda Hernández, Yeny Zulay Castellanos Domínguez, Juan Guillermo Pérez Carreño, Eliana Váquiro Herrera, Victor M. Herrera, Juan Carlos Villar, Nilda Graciela Prado
Publikováno v:
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Trials
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Universidad del Rosario
instacron:Universidad del Rosario
Trials
Trials, Vol 20, Iss 1, Pp 1-10 (2019)
Background Either benznidazole (BZN) or nifurtimox (NFX) is recommended as equivalent to treat Trypanosoma cruzi infection. Nonetheless, supportive data from randomised trials is limited to individuals treated with BZN in southern cone countries of L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c9524fffce18b4429909ec7ca8413c1
https://repository.urosario.edu.co/handle/10336/23396
https://repository.urosario.edu.co/handle/10336/23396
Publikováno v:
Therapeutic Advances in Cardiovascular Disease. 7:237-245
Background: The extent to which treatment with amlodipine/losartan may help patients and their doctors from Andean countries to reach their treatment goals remains unknown. Methods: We conducted a quasi-experimental, validation study in which patient
Publikováno v:
Iatreia. 24
Introducción: la enfermedad cerebrovascular (ECV) se encuentra entre las primeras causas de morbilidad y mortalidad en adultos en todo el mundo. Comparte con la enfermedad cardiovascular factores de riesgo modificables y no modificables; constituye